Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furio Pacini

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Surgery|December 20, 2002
Minimally invasive video-assisted thyroidectomy for papillary carcinoma: a prospective study of its completenessPaolo Miccoli, Rossella Elisei, Gabriele Materazzi, et al.
Annals of Internal Medicine|September 11, 2003
Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigensLuca Chiovato, Francesco Latrofa, Lewis E Braverman, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2009
Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosisMahesh Subramanian, Tania Pilli, Palash Bhattacharya, et al.
Endocrine|February 15, 2019
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancerSilvia Cantara, Eugenio Bertelli, Rossella Occhini, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawalFurio Pacini, Eleonora Molinaro, Maria Grazia Castagna, et al.
European Thyroid Journal|January 4, 2022
2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?Furio Pacini, Dagmar Fuhrer, Rossella Elisei, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general populationRossella Elisei, Barbara Cosci, Cristina Romei, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2006
Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acidRossella Elisei, Agnese Vivaldi, Raffaele Ciampi, et al.
Obesity Surgery|April 6, 2017
Bariatric Surgery Reduces Serum Anti-mullerian Hormone Levels in Obese Women With and Without Polycystic Ovarian SyndromeFrancesco Chiofalo, Cristina Ciuoli, Caterina Formichi, et al.
European Journal of Endocrinology|April 19, 2013
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patientsMaria Grazia Castagna, Gabriele Cevenini, Alexandra Theodoropoulou, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Surgery|December 20, 2002
Minimally invasive video-assisted thyroidectomy for papillary carcinoma: a prospective study of its completenessPaolo Miccoli, Rossella Elisei, Gabriele Materazzi, et al.
Annals of Internal Medicine|September 11, 2003
Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigensLuca Chiovato, Francesco Latrofa, Lewis E Braverman, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2009
Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosisMahesh Subramanian, Tania Pilli, Palash Bhattacharya, et al.
Endocrine|February 15, 2019
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancerSilvia Cantara, Eugenio Bertelli, Rossella Occhini, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawalFurio Pacini, Eleonora Molinaro, Maria Grazia Castagna, et al.
European Thyroid Journal|January 4, 2022
2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?Furio Pacini, Dagmar Fuhrer, Rossella Elisei, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general populationRossella Elisei, Barbara Cosci, Cristina Romei, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2006
Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acidRossella Elisei, Agnese Vivaldi, Raffaele Ciampi, et al.
Obesity Surgery|April 6, 2017
Bariatric Surgery Reduces Serum Anti-mullerian Hormone Levels in Obese Women With and Without Polycystic Ovarian SyndromeFrancesco Chiofalo, Cristina Ciuoli, Caterina Formichi, et al.
European Journal of Endocrinology|April 19, 2013
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patientsMaria Grazia Castagna, Gabriele Cevenini, Alexandra Theodoropoulou, et al.
Pageof 15